Archive: May, 2016

 

 

Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2016

DUBLIN, Ireland, May 12, 2016 (GLOBE NEWSWIRE) -- Link here. Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced its financial results for the three and nine-month periods ended March 31, 2016.

Read more about Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2016

AmpliPhi Biosciences Reports First Quarter 2016 Financial Results and Provides Corporate Update

SAN DIEGO, May 12, 2016 – Link here. AmpliPhi Biosciences Corporation (NYSEMKT: APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, today announced its...

Read more about AmpliPhi Biosciences Reports First Quarter 2016 Financial Results and Provides Corporate Update

Avita’s ReNovaCell™ Offers Advantages in Skin Repigmentation of Burn Scars

Northridge, CA, Perth, Australia and Cambridge, UK, 9 May 2016. Link here.

Read more about Avita’s ReNovaCell™ Offers Advantages in Skin Repigmentation of Burn Scars

Nexvet and Zenoaq Announce PD-1 mAb Candidate for Canine Cancer & USDA Regulatory Jurisdiction Confirmed

DUBLIN, Ireland, May 02, 2016 (GLOBE NEWSWIRE) - Link here - Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, and Zenoaq (Nippon Zenyaku Kogyo Co., Ltd.), a leading Japanese animal health...

Read more about Nexvet and Zenoaq Announce PD-1 mAb Candidate for Canine Cancer & USDA Regulatory Jurisdiction Confirmed

AVH - ReCell Reduces Long-Term Scarring and Itching Outcomes in Pediatric Burns Treatment

Northridge, CA and Cambridge, UK, 6 May 2016 - Link here.

Read more about AVH - ReCell Reduces Long-Term Scarring and Itching Outcomes in Pediatric Burns Treatment

Avita Medical’s ReCell Technology Demonstrated at Vitiligo Conferences in China

Northridge, CA, USA, Perth, Australia and Cambridge, United Kingdom, 3 May 2016 - Link here.

Read more about Avita Medical’s ReCell Technology Demonstrated at Vitiligo Conferences in China

SeaDragon – Market Update

NZX / MEDIA RELEASE 26 April 2016. Link here.

Read more about SeaDragon – Market Update

Avita Medical – Shareholder Letter

29 April, 2016. Link here.

Read more about Avita Medical – Shareholder Letter

AVH - International Experts Honoured with Awards at 4th Annual Skin Regeneration Symposium

April 22, 2016. Link here.

Read more about AVH - International Experts Honoured with Awards at 4th Annual Skin Regeneration Symposium

AmpliPhi Biosciences Provides Update on Phase I Trial: Phage Therapy Well Tolerated in First Cohort

SAN DIEGO, April 20, 2016– Link here. AmpliPhi Biosciences Corporation (NYSEMKT: APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, today provided an update...

Read more about AmpliPhi Biosciences Provides Update on Phase I Trial: Phage Therapy Well Tolerated in First Cohort

1 2 3